DAFTAR PUSTAKA
1. Riset Kesehatan Dasar, Badan Penelitian dan Pengembangan
Kesehatan Kementrian Kesehatan RI,2013.
2. Kementrian kesehatan Republik Indonesia prosiding dari: Tahun 2030
prevalensi diabetes melitus di Indonesia mencapai 21,3 juta orang,
pusat komunikasi publik sekretariat departemen kesehatan, November
2009. http/www/depkes.go.id/article/414.
3. Port CM. Diabetes mellitus and metabolic syndrome. In : Essential of
Pathophysiology Lippincot Williams and Wilkins 2011.p.799-813.
4. Powers CA. Diabetes Mellitus. Dalam: Kasper LD, Fauci SA, Longo
LD, et al editors. Harrison’s Endocrinology 16th ed Mc Graw
Hill;2006.p.283-292.
5. Kahn ES, Porte D. The pathophysiology and genetics of type 2
diabetes mellitus. in : Inzucchi S, Porte D, Sherwin SR, et al editors.
The diabetes mellitus manual: A primary care companion to ellenberg
and rifkin’s 6th ed. Mc Graw Hill; 2005.p.51-54.
6. Masharani U, Karam JH. Pancreatic hormones and diabetes mellitus.
in: Greenspan FS, Gardner GD editors. Basic and clinical
endocrinology 6th ed Mc Graw Hill;2001.p.636-7.
7. Consensus statement on the worldwide standardisation of the HbA1c
measurement, The American Diabetes Association, European
Clinical Chemistry and Laboratory Medicine, and the International
Diabetes Federation, Diabetologia,10.1007/s00125-007-0789-7.
8. Ganong WF.Review of medical physiology (Widjajakusumah
HM,trans).USA:McGraw-Hill:2001.p.450-60
9. Ozbek N.Concise review: Absorption and transport of iron. Medical
Journal Of Islamic World Academy Of Sciences 2010;18(4):133-8.
10. Cook JD, Skikne BS, Baynes RD. Serum transferrin receptor.
Annu.Rev.Med 1993;44:63-74
11. Andrew CN, Iron deficiency and related disorders, in : Greer JP,
Foerster J, Rodgers GM, et al., editors. Wintrobe’s clinical hematology.
12nd ed. Philadelphia: Lippincott Williams & Wilkins; 2009.p.810-827.
12. Huebers HA, Beguin Y, Pootrakul P, et al. Intact Transferrin Receptor
in Human Plasma Their Relationship to Erythropoeisis. The American
Society of Hematology. Blood 1990;75(10): 102-107.
13. Mast AE, Blinder MA, Gronowski AM et al. Clinical utility of the soluble
transferrin receptor and comparison with serum ferritin in several
populations. Clinical Chemistry 1998;44:.45-51.
14. Nadeem S, Shah S, Iqbal T et al. Serum transferrin receptor, serum
ferritin and serum transferrin receptor-ferritin index in adults witn iron
deficiency anemia. Available http://www.ayubmed.44
15. Real JMF, Moreno JM, Bermejo AL. Circulating soluble transferrin
receptor according to glucose tolerance status and insulin sensitivity.
Diabetes care 2007:30.p.604-608.
16. Hernandez C, Lecube A, Carrera A, et al. Soluble transferrin receptors
and ferritin in type 2 diabetic patients. Diabetic Medicine
2004;22:97-101.
17. Montonen J, Boeing H, Steffen A,et al, Body iron stores and risk of
type 2 diabetes:results from the european prospective investigation
into cancer and nutrition (EPIC)- postdam study, Diabetologia 2012,
55: 2613-2621.
18. Real JMF, Izquierdo M, Moreno-Navarette JM et al, Circulating soluble
transferrin receptor concentration decreases after exercise-induced
improvement of insulin sensitivity in obese individuals, International
journal of obesity, 2009,33: 768-774.
19. Real JMF,Ricart W, Bermejo AL. Perspective in diabetes, Cross talk
between iron metabolism and diabetes. Diabetes 2002:51:2348-235.
20. Salonen TJ, Tuomainen TP, Nyyssonen K et al. Relation between iron
stores and non-insulin dependent diabetes in men:case-control study.
BMJ 1998;317:727.
21. Skikne SB. Serum transferrin receptor. Am J Hematol
22. Berlin TB, Meyer A, Pikielny R et al. Soluble transferrin receptor as a
diagnostic laboratory test for detection of iron deficiency anemia in
acute illness of hospitalized patients. 2011;IMA J (13).p.96-98.
23. De Block CEM, Campenhout CM, Leeuw IH et al. Soluble Transferrin
Receptor Level. Diabetes care 2000:23:1384-8.
24. Sacher R, MC Pherson RA. .Tinjauan Klinis Hasil pemeriksaan
Laboratorium. 2004 . Hal 38-40, 48-49.
25. Jacobsson S. The clinical value of serum transferin
measurement.Available from:URL:http/www.ifcc org/ejifcc/vol 13 no
2/1301200106.htm. Diunduh tanggal 13 Mei 2014.
26. Worwood M, May A. Iron deficiency anemia and iron overload.in : Bain
BJ, Bates I, Laffan MA, Lewis SM, editors. Dacie & Lewis practical
hematology. 11th ed. Philadelphia: Elsevier Churchill Livingstone; 2011.
p.132-150
27. Henrika F.Peran Transferin dalam diagnostik laboratorium. Dalam:
Oesman F, Timan IS,editor. Pendidikan Berkesinambungan Patologi
Klinik :2012.p.1-9
28. Andrews NC. Disorders of Iron Metabolism. New England Journal of
Medicine.1999; 341(26):1986-95
29. Tuomainen TP,Nyssonen K,Salonen R, et al. Body iron stores are
30. Hoffbrand AV, Hershko C, Camaschella C, Iron metabolism, iron
deficiency and disorders of haem synthesis, in : Hoffbrand VA,
Catovsky D, Tuddenham GD, et al, editors Postgraduate hematology.
6th ed. Massachusetts: Blackwell Publishing Ltd; 2011. p.26-45
31. Pai HS, Choi JW. Association between serum transferrin receptor
concentrations and erythropoietic activities according to body iron
status. Annals of Clinical and laboratory Science.2003;33(3):279-284.
32. Wish BJ. Assesing iron status:Beyond serum ferritin and transferrin
saturation. Am J Clin Nephrol 1.2006;S4-S8.
33. Cooper, M.J. and Zlotkin, S.H. Day-to-day variation of transferrin
receptor and ferritin in healthy men and women,Am. J. Clin. Nutr.,64:
738–742, 1996.
34. Allen J, Kristin RB, Cooper AJ, et al. Measurement of soluble
transferrin receptor in serum of healthy adults. Clinical chemistry
J.1998;44(1):35-39
35. Provan D. Iron Deficiency Anemia. Dalam ABC of Clinical Hematology
3rd ed, Blackwell publishing; 2007.p. 1-5
36. PERKENI.Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus
tipe 2 di Indonesia. 2015. Jakarta 2011: 1- 14.
37. Daniel, W. Foster. Diabetes Mellitus. Dalam : Harrison. Prinsip-prinsip
Ilmu Penyakit Dalam. Penerbitan EGC Yogyakarta 1995 : 13 (5)
38. Purnamasari D. Diagnosis dan klassifikasi diabetes mellitus. Dalam
Sudoyo AW, Setiyohadi B, Alwi i et al editors Buku Ajar Ilmu Penyakit
Dalam edisi 5:2009.p.1880-4.
39. American Diabetes Association (ADA): Diagnosis and Classification of
Diabetes Mellitus 2012.Diabetes care (suppl 1) 2012.
40. Inzucchi ES. Classification and diagnosis of diabetes mellitus. In :
Inzucchi S, Porte D, Sherwin SR, et al editors. The diabetes mellitus
manual: A primary care companion to ellenberg and rifkin’s 6th ed. Mc
Graw Hill; 2005.p.1-15.
41. Definition and diagnostic criteria for diabetes mellitus and other
categories of glucose intolerance. World Health
Organization.1999.p.2-13.
42. Buse JB, Polonsky KS, Burant CE. Type 2 diabetes mellitus. in:
Kronenberg HM, Melmed S, Polonsky KS et al editors Williams
Textbook of Endocrinology 11th ed Saunders Elseviers;
2008.p.1330-1332.
43. Codario RA. Pathophysiology of type 2 diabetes.in : Type 2 Diabetes,
Pre Diabetes and The Metabolic Syndrome. Humana Press; 2005.p.
1-9
44. Lakso M. Epidemiology of type 2 diabetes. in: Goldstein BJ, Wieland
45. Stumvoll M, Goldstein BJ, Haeften TW. Pathogenesis of type 2
diabetes. in : Goldstein BJ, Wieland DM editors.Type 2 Diabetes
Principles and Practice 2nd ed Informa healthcare 2008.p.13-20
46. Swaminathan S, Fonseca V, Alam GM, et al. The role of iron in
diabetes and its complication. American Diabetes Association
2007;30(7):1926-1930.
47. Shousa-Abou, El-Megeed M.H, Sultan H.K, Interleukin-8, Ferritin and
soluble transferrin receptors in type 2 diabetes mellitus, Egyptian
Journal of immunology,2006:vol:13(1),p: 19-25.
48. World Health Organization (2011), Haemoglobin concentrations for the
diagnosis of anaemia and assesment of severity, Vitamins and mineral
nutrition information system.
49. Wilson G.J, Linquist J.H, Grambow SC, et al, Potential role of
increasing iron stores in Diabetes, Am.J.Med
Sci,2003;325(6):332-339.
50. Gopinath b, Sri sai prasad m, Jayarama n, Prabhakara k, Study of
factors associated with poor glycemic control in type -2 diabetic
patients, Global journal of medicine and public health,vol(2),no 2;2013.
51. Sharif A, Younus S, Baig K et al, Prevalence and Risk of Anemia in
52. Ruhul Md, Sharmin, Luthfor et al, Ferritin and Soluble Transferrin
Receptors in Type 2 Diabetic and Non-diabetic Post-menopausal
Women in Dhaka, Bangladesh Mal J Nutr 16(3): 369 - 377, 2010.
53. Rajapathak SN, Rosett J.W, Gunter .M.J et al, Biomakers of iron
stores and risk of developing type 2 diabetes, Diabetes, Obesity and
Metabolism, 11, 2009, 472–479.
54. Ho CH, You JY, Chau WK et al, Diagnostic value of serum transferrin
receptor and glycosylated hemoglobin on hemolytic anemia, Ann
